Quick search for therapies
7 results (filtered)
Page 1 / 1
1
Doruk, A.; Uzun, O.; Ozsahin, A.
A placebo-controlled study of extract of Ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia
Int Clin Psychopharmacol, 2008, 23(4), 223-227
A placebo-controlled study of extract of Ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia
Int Clin Psychopharmacol, 2008, 23(4), 223-227
Ginkgo, Clinical research, Complementary and alternative medicine, Phytomedicine, Placebo-controlled, Mental diseases, Randomized trial, Schizophrenia
2
Atmaca, M.; Tezcan, E.; Kuloglu, M.; Ustundag, B.; Kirtas, O.
The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia
Psych Clin Neurosci, 2005, 59, 652-656
The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia
Psych Clin Neurosci, 2005, 59, 652-656
Ginkgo, Clinical research, Complementary and alternative medicine, Phytomedicine, Mental diseases, Randomized trial, Schizophrenia
3
Zhang, X.Y.; Zhou, D.F.; Cao, L.Y.; Wu, G.Y.
The effects of Ginkgo biloba extract added to haloperidol on pheripheral T cell subsets in drug-free schizophrenia
A double-blind, placebo-controlled trial
Psychopharmacol, 2006, 188, 12-17
The effects of Ginkgo biloba extract added to haloperidol on pheripheral T cell subsets in drug-free schizophrenia
A double-blind, placebo-controlled trial
Psychopharmacol, 2006, 188, 12-17
Ginkgo, Clinical research, Complementary and alternative medicine, Phytomedicine, Placebo-controlled, Mental diseases, Randomized trial, Schizophrenia
4
Chen, E.Y.H.; Hui, C.L.M.
HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia
A double-blind, placebo-controlled study
Phytother Res, 2012, 26(8), 1166-1172
HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia
A double-blind, placebo-controlled study
Phytother Res, 2012, 26(8), 1166-1172
Clinical research, Complementary and alternative medicine, Phytomedicine, Placebo-controlled, Mental diseases, Randomized trial, Schizophrenia, Panax, Panax quinquefolius
5
Miyaoka, T.; Wake, R.; Furuya, M.; Liaury, K.; Ieda, M.; Kawakami, K.; Tsuchie, K.; Fukushima, M.; Ishihara, K.; Araki, T.; Hashioka, S.; Horiguchi, J.
Yokukansan (TJ-54) for treatment of very-late-onset schizophrenia-like psychosis
An open-label study
Phytomed, 2013, 20(7), 654-658
Yokukansan (TJ-54) for treatment of very-late-onset schizophrenia-like psychosis
An open-label study
Phytomed, 2013, 20(7), 654-658
Observational trial, Clinical research, Kombinationsarzneimittel, Complementary and alternative medicine, Phytomedicine, Mental diseases, Psychosis, Schizophrenia, Yokukansan
6
Agnihotri, A.P.; Sontakke, S.D.; Thawani, V.R.; Saoji, A.; Goswami, V.S.S.
Effects of Withania somnifera in patients of schizophrenia
A randomized, double blind, placebo controlled pilot trial study
Ind J Pharmacol, 2013, 45(4), 427-418
Effects of Withania somnifera in patients of schizophrenia
A randomized, double blind, placebo controlled pilot trial study
Ind J Pharmacol, 2013, 45(4), 427-418
Ayurveda, Clinical research, Complementary and alternative medicine, Phytomedicine, Placebo-controlled, Mental diseases, Randomized trial, Schizophrenia, Withania, Withania somnifera
7
Hoch, E.; Niemann, D.; Keller, R. von; Schneider, M.; Friemel, C.M.; Preuss, U.W.; Hasan, A.; Pogarell, O.
How effective and safe is medical cannabis as a treatment of mental disorders?
A systematic review
Eur Arch Psych Clin Neurosci, 2019, epub ahead of print,
How effective and safe is medical cannabis as a treatment of mental disorders?
A systematic review
Eur Arch Psych Clin Neurosci, 2019, epub ahead of print,
Anxiety, Cannabis, Cannabis sativa, ADHD, Clinical research, Complementary and alternative medicine, Phytomedicine, Mental diseases, Psychosis, Schizophrenia, Systematic review, Tourette syndrome, Trauma, Appetitlosigkeit